Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.

Roché, Henri; Conte, Pierfranco; Perez, Edith A; Sparano, Joseph A; Xu, Binghe; Jassem, Jacek; Peck, Ronald; Kelleher, Thomas; Hortobagyi, Gabriel N

Roché, Henri; Conte, Pierfranco; Perez, Edith A; Sparano, Joseph A; Xu, Binghe; Jassem, Jacek; Peck, Ronald; Kelleher, Thomas; Hortobagyi, Gabriel N.

Affiliation

Roché H; Institut Claudius Regaud, 20-24 rue du Saint Pierre, 31052, Toulouse Cedex, France. Roche.Henri@claudiusregaud.fr

Breast Cancer Res Treat ; 125(3): 755-65, 2011 Feb.

Article in En | MEDLINE | ID: mdl-21128114

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Anthracyclines / Epothilones / Taxoids Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2011 Document type: Article Affiliation country: Francia Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google